首页 | 本学科首页   官方微博 | 高级检索  
     

吉西他滨联合顺铂治疗蒽环类及紫杉类耐药转移性乳腺癌的临床观察
引用本文:朱益平,程静,吉兆宁. 吉西他滨联合顺铂治疗蒽环类及紫杉类耐药转移性乳腺癌的临床观察[J]. 皖南医学院学报, 2009, 28(2): 109-111
作者姓名:朱益平  程静  吉兆宁
作者单位:皖南医学院附属弋矶山医院,肿瘤内科,安徽,芜湖,241001
摘    要:目的:观察吉西他滨(Gemcitabine)联合顺铂(Cisplatin)治疗蒽环类及紫杉类耐药转移性乳腺癌的疗效及耐受性。方法:应用Gemcitabine 1000mg/m2静脉滴注d1d8,Cisplatin 20mg/m2,静脉滴注,d2~5,21d为一周期。结果:全组24例,其中CR1例、PR9例、SD9例、PD5例,总有效率41.7%。结论:吉西他滨联合顺铂治疗蒽环类及紫杉类耐药转移性乳腺癌疗效肯定,毒副反应能耐受。

关 键 词:乳腺癌  吉西他滨  顺铂  蒽环类  紫杉类  化疗

Gemcitabine and cisplatin combination chemotherapy as alternative agents for metastatic breast cancer patients with anthracycline and taxane resistance
ZHU Yi-ping,CHENG Jing,JI Zhao-ning. Gemcitabine and cisplatin combination chemotherapy as alternative agents for metastatic breast cancer patients with anthracycline and taxane resistance[J]. Acta Academiae Medicinae Wannan, 2009, 28(2): 109-111
Authors:ZHU Yi-ping  CHENG Jing  JI Zhao-ning
Affiliation:(Department of Oncology, Yijishan Hospital, Wannan Medical University Wuhu 241001, China)
Abstract:Objective: To observe the therapeutic effect and drug tolerance of gemcitabine and cisplatin combination chemotherapy in treating metastatic breast cancer patients complicated with anthracycline and taxane resistance. Methods : Gemcitabine and cisplatiu were administered by intravenous drip at a dose of 1000mg/m^2 ( on day 1 and day 8 ) and 20 mg/m^2 ( from day 2 to day 5 ), respectively, in a treatment period of 3 weeks. Results : Of the 24 patients, 1 achieved' complete response ,9 were found partial response and another 9, stable disease and progressive disease was found in 5.41.7% of patients responded to the chemotherapy. Conclusion:Gemcitabine combined with eisplatin is an effective and tolerable regimen in treatment of metastatic breast cancer patients with drug resistance of anthracycline and taxane.
Keywords:breast cancer  gemcitabine  cisplatin  anthracycline  taxane  chemotherapy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号